Several significant targetable pathways in lung adenocarcinoma have been discovered, including the Epidermal Growth Factor Receptor (EGFR), PI3K/AKT/mTOR, and RAS-MAPK pathways [9, 10]. The gene discussed is EGFR; the disease is lung adenocarcinoma.